DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly

被引:216
|
作者
Litovchick, Larisa [1 ,2 ]
Florens, Laurence A. [3 ]
Swanson, Selene K. [3 ]
Washburn, Michael P. [3 ,4 ]
DeCaprio, James A. [1 ,2 ,5 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[2] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA
[3] Stowers Inst Biomed Res, Kansas City, MO 64110 USA
[4] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA
[5] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02215 USA
关键词
retinoblastoma-like protein p130; growth arrest; cell cycle; Down syndrome; phosphorylation; cellular senescence; CELL-CYCLE CONTROL; IN-VIVO; CAENORHABDITIS-ELEGANS; TUMOR-SUPPRESSOR; DOWN-SYNDROME; B-MYB; E2F; DROSOPHILA; PRB; IDENTIFICATION;
D O I
10.1101/gad.2034211
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In the absence of growth signals, cells exit the cell cycle and enter into G0 or quiescence. Alternatively, cells enter senescence in response to inappropriate growth signals such as oncogene expression. The molecular mechanisms required for cell cycle exit into quiescence or senescence are poorly understood. The DREAM (DP, RB [retinoblastoma], E2F, and MuvB) complex represses cell cycle-dependent genes during quiescence. DREAM contains p130, E2F4, DP1, and a stable core complex of five MuvB-like proteins: LIN9, LIN37, LIN52, LIN54, and RBBP4. In mammalian cells, the MuvB core dissociates from p130 upon entry into the cell cycle and binds to BMYB during S phase to activate the transcription of genes expressed late in the cell cycle. We used mass spectroscopic analysis to identify phosphorylation sites that regulate the switch of the MuvB core from BMYB to DREAM. Here we report that DYRK1A can specifically phosphorylate LIN52 on serine residue 28, and that this phosphorylation is required for DREAM assembly. Inhibiting DYRK1A activity or point mutation of LIN52 disrupts DREAM assembly and reduces the ability of cells to enter quiescence or undergo Ras-induced senescence. These data reveal an important role for DYRK1A in the regulation of DREAM activity and entry into quiescence.
引用
收藏
页码:801 / 813
页数:13
相关论文
共 50 条
  • [31] The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target
    Rammohan, Malini
    Harris, Ethan
    Bhansali, Rahul S.
    Zhao, Emily
    Li, Loretta S.
    Crispino, John D.
    ONCOGENE, 2022, 41 (14) : 2003 - 2011
  • [32] Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome
    Meijer, Laurent
    Chretien, Emilie
    Ravel, Denis
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 : S95 - S113
  • [33] The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome
    Jerzy Wegiel
    Karol Dowjat
    Wojciech Kaczmarski
    Izabela Kuchna
    Krzysztof Nowicki
    Janusz Frackowiak
    Bozena Mazur Kolecka
    Jarek Wegiel
    Wayne P. Silverman
    Barry Reisberg
    Mony deLeon
    Thomas Wisniewski
    Cheng-Xin Gong
    Fei Liu
    Tatyana Adayev
    Mo-Chou Chen-Hwang
    Yu-Wen Hwang
    Acta Neuropathologica, 2008, 116 : 391 - 407
  • [34] The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells
    Khor, Bernard
    Gagnon, John D.
    Goel, Gautam
    Roche, Marly I.
    Conway, Kara L.
    Tran, Khoa
    Aldrich, Leslie N.
    Sundberg, Thomas B.
    Paterson, Alison M.
    Mordecai, Scott
    Dombkowski, David
    Schirmer, Melanie
    Tan, Pauline H.
    Bhan, Atul K.
    Roychoudhuri, Rahul
    Restifo, Nicholas P.
    O'Shea, John J.
    Medoff, Benjamin D.
    Shamji, Alykhan F.
    Schreiber, Stuart L.
    Sharpe, Arlene H.
    Shaw, Stanley Y.
    Xavier, Ramnik J.
    ELIFE, 2015, 4 : 1 - 27
  • [35] The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome
    Wegiel, Jerzy
    Dowjat, Karol
    Kaczmarski, Wojciech
    Kuchna, Izabela
    Nowicki, Krzysztof
    Frackowiak, Janusz
    Kolecka, Bozena Mazur
    Wegiel, Jarek
    Silverman, Wayne P.
    Reisberg, Barry
    deLeon, Mony
    Wisniewski, Thomas
    Gong, Cheng-Xin
    Liu, Fei
    Adayev, Tatyana
    Chen-Hwang, Mo-Chou
    Hwang, Yu-Wen
    ACTA NEUROPATHOLOGICA, 2008, 116 (04) : 391 - 407
  • [36] A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition
    Kim, Hyeongki
    Lee, Kyu-Sun
    Kim, Ae-Kyeong
    Choi, Miri
    Choi, Kwangman
    Kang, Mingu
    Chi, Seung-Wook
    Lee, Min-Sung
    Lee, Jeong-Soo
    Lee, So-Young
    Song, Woo-Joo
    Yu, Kweon
    Cho, Sungchan
    DISEASE MODELS & MECHANISMS, 2016, 9 (08) : 839 - 848
  • [37] Development of DANDYs, New 3,5-Diaryl-7-azaindoles Demonstrating Potent DYRK1A Kinase Inhibitory Activity
    Gourdain, Stephanie
    Dairou, Julien
    Denhez, Clement
    Bui, Linh Chi
    Rodrigues-Lima, Fernando
    Janel, Nathalie
    Delabar, Jean M.
    Cariou, Kevin
    Dodd, Robert H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (23) : 9569 - 9585
  • [38] NFATc1 phosphorylation by DYRK1A increases its protein stability
    Liu, Heng
    Wang, Ketao
    Chen, Shuai
    Sun, Qian
    Zhang, Yuankai
    Chen, Long
    Sun, Xiulian
    PLOS ONE, 2017, 12 (02):
  • [39] Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass
    Rachdi, Latif
    Kariyawasam, Dulanjalee
    Guez, Fanny
    Aiello, Virginie
    Arbones, Maria L.
    Janel, Nathalie
    Delabar, Jean-Maurice
    Polak, Michel
    Scharfmann, Raphael
    DIABETOLOGIA, 2014, 57 (05) : 960 - 969
  • [40] Dyrk1A Influences Neuronal Morphogenesis Through Regulation of Cytoskeletal Dynamics in Mammalian Cortical Neurons
    Martinez de Lagran, M.
    Benavides-Piccione, R.
    Ballesteros-Yanez, I.
    Calvo, M.
    Morales, M.
    Fillat, C.
    DeFelipe, J.
    Ramakers, G. J. A.
    Dierssen, M.
    CEREBRAL CORTEX, 2012, 22 (12) : 2867 - 2877